Perth, Oct 24, 2007 (ABN Newswire) - HELICON GROUP LIMITED (ASX: HCG) announced today the relocation of its CEO, Mr Peter Abrahamson to Shanghai to oversee the implementation of its China Strategy.
"Locating our key executive to be close to our customers and partners is critically important to the success of our plans" commented Helicon's Chairman, Dr Saliba Sassine.
"Mr Abrahamson is a highly experienced international executive. He has a proven track record in Asia with his previous roles heading Allergan's and AMO's operations in Asia covering nine countries, including China," said Dr Sassine. "Mr Abrahamson is returning to familiar ground and exciting challenges."
Helicon is a specialty pharmaceutical company that licenses proven proprietary products and drives their market value growth in China, the world's fastest growing pharmaceutical market. The company already owns the rights to three such products which are at various stages of the regulatory process. Helicon is also actively seeking to add to its portfolio and is negotiating with various groups for the rights to the China and other North Asian markets.
"Being on the ground in China is really the best way to build Helicon' franchise and I am looking forward to returning to this dynamic part of the world to drive the growth of our business" commented Peter Abrahamson.
About Helicon Group Limited
Helicon is listed on the Australian Securities Exchange. The Company's business is to identify and exploit niche market opportunities in the biomedical markets of North Asia, specifically China and to participate in the significant growth that has been projected for these markets over the next 25 years.
Helicon looks for "Special Situations" for advanced Western biopharmaceutical products that are not available in China or other North Asian Markets or where there are market needs that are not being adequately provided for.
Helicon's product partners are likely to be innovative small to medium sized pharmaceutical and healthcare enterprises focused largely on western markets.
Helicon seeks exclusive licenses for the designated markets and utilises a low cost operating overhead base in combination with established channel partners for product registration, distribution, marketing, and sales.
Contact
Peter Abrahamson Helicon Group Limited Tel: +61 411 336 330 Email: peter@helicongroup.com.au Website: www.helicongroup.com.au
News 
